An analysis of a subcohort of prospectively observed, initially healthy, postmenopausal women of the UKCTOCS study who developed breast cancer 12–24 months after sample collection, showed that high RANKL and progesterone serum levels led to a 5.3-fold increase of breast cancer risk [34]. Here, TNFSF11 is linked to breast cancer.